Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-20-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity is to stimulate new and innovative multidisciplinary research in the area of long acting therapeutics for HIV and HIV-associated tuberculosis (TB) and viral hepatitis B and C. Applications are sought that lead to new effective therapies for administration once per month or less frequently as oral, injectable, implantable, or transdermal products.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding